Working… Menu
Trial record 2 of 2 for:    NCT02117765

Clinical Phase II/III Trial of Ustekinumab to Treat Type 1 Diabetes (UST1D2) (UST1D2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03941132
Recruitment Status : Recruiting
First Posted : May 7, 2019
Last Update Posted : January 29, 2021
Juvenile Diabetes Research Foundation
Janssen, LP
Information provided by (Responsible Party):
Jan Dutz, University of British Columbia

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 2024
Estimated Study Completion Date : August 2025